Reduced plakoglobin increases the risk of sodium current defects and atrial conduction abnormalities in response to androgenic anabolic steroid abuse
Laura C. Sommerfeld,Andrew P. Holmes,Ting Y. Yu,Christopher O'Shea,Deirdre M. Kavanagh,Jeremy M. Pike,Thomas Wright,Fahima Syeda,Areej Aljehani,Tania Kew,Victor R. Cardoso,S. Nashitha Kabir,Claire Hepburn,Priyanka R. Menon,Sophie Broadway‐Stringer,Molly O'Reilly,Anika Witten,Lisa Fortmueller,Susanne Lutz,Alexandra Kulle,Georgios V. Gkoutos,Davor Pavlovic,Wiebke Arlt,Gareth G. Lavery,Richard Steeds,Katja Gehmlich,Monika Stoll,Paulus Kirchhof,Larissa Fabritz
DOI: https://doi.org/10.1113/jp284597
2024-02-13
The Journal of Physiology
Abstract:figure legend Atrial arrhythmias (AA) can be a clinical manifestation of advanced arrhythmogenic right ventricular cardiomyopathy (ARVC), and a male preponderance can be observed. Patients with ARVC show atrial conduction abnormalities on ECG. In a murine experimental ARVC model, low expression of the ARVC‐associated protein plakoglobin (Plako+/−) combined with androgenic anabolic steroid (male sex hormone) exposure led to ECG P wave abnormalities. This was combined with reduced sodium channel (NaV1.5) clustering and decreased peak Na+ current, leading to atrial conduction abnormalities, a substrate for arrhythmias. Androgenic anabolic steroids (AAS) are commonly abused by young men. Male sex and increased AAS levels are associated with earlier and more severe manifestation of common cardiac conditions, such as atrial fibrillation, and rare ones, such as arrhythmogenic right ventricular cardiomyopathy (ARVC). Clinical observations suggest a potential atrial involvement in ARVC. Arrhythmogenic right ventricular cardiomyopathy is caused by desmosomal gene defects, including reduced plakoglobin expression. Here, we analysed clinical records from 146 ARVC patients to identify that ARVC is more common in males than females. Patients with ARVC also had an increased incidence of atrial arrhythmias and P wave changes. To study desmosomal vulnerability and the effects of AAS on the atria, young adult male mice, heterozygously deficient for plakoglobin (Plako+/−), and wild type (WT) littermates were chronically exposed to 5α‐dihydrotestosterone (DHT) or placebo. The DHT increased atrial expression of pro‐hypertrophic, fibrotic and inflammatory transcripts. In mice with reduced plakoglobin, DHT exaggerated P wave abnormalities, atrial conduction slowing, sodium current depletion, action potential amplitude reduction and the fall in action potential depolarization rate. Super‐resolution microscopy revealed a decrease in NaV1.5 membrane clustering in Plako+/− atrial cardiomyocytes after DHT exposure. In summary, AAS combined with plakoglobin deficiency cause pathological atrial electrical remodelling in young male hearts. Male sex is likely to increase the risk of atrial arrhythmia, particularly in those with desmosomal gene variants. This risk is likely to be exaggerated further by AAS use. Key points Androgenic male sex hormones, such as testosterone, might increase the risk of atrial fibrillation in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), which is often caused by desmosomal gene defects (e.g. reduced plakoglobin expression). In this study, we observed a significantly higher proportion of males who had ARVC compared with females, and atrial arrhythmias and P wave changes represented a common observation in advanced ARVC stages. In mice with reduced plakoglobin expression, chronic administration of 5α‐dihydrotestosterone led to P wave abnormalities, atrial conduction slowing, sodium current depletion and a decrease in membrane‐localized NaV1.5 clusters. 5α‐Dihydrotestosterone, therefore, represents a stimulus aggravating the pro‐arrhythmic phenotype in carriers of desmosomal mutations and can affect atrial electrical function.
neurosciences,physiology